Healthcare Services

Cardiac Resynchronization Therapy Market Revenue Expected to Reach $8.96 Billion by 2030 with 5.7% CAGR

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Cardiac Resynchronization Therapy Market Evolve From 2026 To 2030?

The cardiac resynchronization therapy market has seen robust expansion in recent years. It is anticipated to grow from $6.72 billion in 2025 to $7.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. The increase observed in the historic period can be linked to the increasing prevalence of heart failure, improved awareness of ventricular dyssynchrony, the expansion of cardiac device implantation centers, advancements in pacemaker technology, and growing clinical evidence supporting crt benefits.

The cardiac resynchronization therapy market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $8.96 billion, expanding at a compound annual growth rate (CAGR) of 5.7%. This projected growth is driven by factors such as the increasing demand for advanced CRT systems, the growing acceptance of remote management for cardiac devices, the expanding elderly population suffering from heart failure, a heightened emphasis on optimizing therapy, and rising investments in technologies for cardiac rhythm management. Key trends expected during this period involve a greater uptake of sophisticated CRT devices, an increase in personalized device programming, the wider integration of remote device monitoring, the spread of minimally invasive implantation methods, and an intensified focus on improving patient outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15531&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Cardiac Resynchronization Therapy Market?

The expansion of the cardiac resynchronization therapy market is anticipated due to the growing occurrence of cardiovascular diseases. These conditions, which encompass illnesses affecting the heart and blood vessels, are becoming more prevalent owing to factors such as an aging populace, unhealthy lifestyles, increased tobacco consumption, sedentary behavior, and inadequate diets. Cardiac resynchronization therapy effectively addresses cardiovascular issues, including heart failure, by enhancing the coordination of the heart’s contractions through the delivery of synchronized electrical impulses. For instance, data released by the Minnesota Department of Health in September 2024 indicated that approximately 30% of adults in Minnesota, totaling nearly 1.4 million people, reported having high blood pressure in 2023. Additionally, in 2022, hypertensive diseases were the underlying or contributing factor in 14,225 deaths, representing almost 28% of all fatalities in the state. Therefore, the increasing prevalence of cardiovascular diseases is significantly driving the growth of the cardiac resynchronization therapy market.

Which Segment Areas Are Covered In The Cardiac Resynchronization Therapy Market Analysis?

The cardiac resynchronization therapy market covered in this report is segmented –

1) By Type: Cardiac Resynchronization Therapy (CRT)-Defibrillator, Cardiac Resynchronization Therapy (CRT)-Pacemaker

2) By Age: Below 44 Years, 45-64 Years, 65-84 Years, Above 85 Years

3) By End-Use: Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers

Subsegments:

1) By Cardiac Resynchronization Therapy (CRT)-Defibrillator: Single-Chamber CRT-D, Dual-Chamber CRT-D, Triple-Chamber CRT-D, Bi-Ventricular CRT-D

2) By Cardiac Resynchronization Therapy (CRT)-Pacemaker: Single-Chamber CRT-P, Dual-Chamber CRT-P, Triple-Chamber CRT-P, Bi-Ventricular CRT-P

What Trends Are Projected To Affect The Cardiac Resynchronization Therapy Market?

Major companies operating in the cardiac resynchronization therapy market are focusing on creating implantable devices, including the cardiac Resynchronization Therapy Device Launch, to enhance real-time hemodynamic optimization and improve patient-specific cardiac pacing outcomes. Cardiac Resynchronization Therapy (CRT) Device Launch signifies the formal introduction of an implantable medical device designed to improve the synchronization of heart chamber contractions in patients experiencing heart failure. For example, in February 2024, MicroPort Scientific Corporation, a China-based medical device company, launched the GALI SonR cardiac resynchronization therapy and defibrillation device (CRT-D), an implantable device, and the Navigo 4LV left ventricular pacing leads in Japan. This product represents the first and only CRT hemodynamic sensor developed to automatically optimize patients once a week and, crucially, while the patient is active, facilitating real-life optimization. The clinically proven SonR algorithm has shown a 35% risk reduction in heart failure hospitalization, and it is also projected to help ensure the well-being and safety of the CRT-D patient.

Which Global Companies Are Actively Competing In The Cardiac Resynchronization Therapy Market?

Major companies operating in the cardiac resynchronization therapy market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co KG, MicroPort Scientific Corporation, LivaNova PLC, Lepu Medical Technology Beijing Co Ltd, Osypka Medical GmbH, EBR Systems Inc, Japan Lifeline Co Ltd, CCC Medical Devices, Shree Pacetronix Ltd, BPL Medical Technologies, Medico Srl, Pacetronix, Lepu Healthcare, Blue Cross Bio Medical, Cardiac Science International, Beijing Jinshi Medical, Suzhou Medical Instrument Factory

Read the full cardiac resynchronization therapy market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-resynchronization-therapy-global-market-report

What Are The Leading Geographic Regions In The Cardiac Resynchronization Therapy Market?

North America was the largest region in the cardiac resynchronization therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac resynchronization therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac Resynchronization Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15531&type=smp

Browse Through More Reports Similar to the Global Cardiac Resynchronization Therapy Market 2026, By The Business Research Company

Rehabilitation Robotics Global Market Report

https://www.thebusinessresearchcompany.com/report/rehabilitation-robotics-global-market-report

Behavioral Rehabilitation Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-rehabilitation-global-market-report

Smart Portable Rehabilitation Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/smart-portable-rehabilitation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795